The global pharmaceutical manufacturing equipment market is anticipated to reach USD 21.24 billion by 2026 and USD 30.39 ...
Pharma’s reputation among patient groups rose last year, but concerns remain over access and pricing
The pharma industry saw its reputation among patient groups inch up last year, a new survey finds, but concerns remain over ...
The US pharmaceutical industry expressed support for the US Food and Drug Administration’s (FDA) proposed framework for ...
Two weeks ago, President Trump sent letters to 17 leading pharmaceutical manufacturers, giving them 60 days to propose plans to lower U.S. drug prices to align with the lowest prices offered in other ...
India hosts more active pharmaceutical ingredient (API) manufacturing sites that are compliant with the U.S. Food and Drug Administration than any country outside the U.S., and it produces more ...
Three pharmaceutical industry veterans today announced the creation of CELYSTRA Pharma, a new Quebec-based biopharmaceutical company specializing in the introduction of innovative treatments to Canada ...
Pharmaceutical Research and Manufacturers of America , founded in 1958, is a trade group representing companies in the pharmaceutical industry in the United States. PhRMA's stated mission is advocacy ...
Today, Pharma.Aero brings together almost 100 stakeholders worldwide across the Life Science and MedTech supply chain, ...
Pharmaceutical Executive: What elements is the conversation about bringing pharma manufacturing home missing? Charlie Lyon: ...
HHS makes first big move against SSRIs; Makary in the hot seat?; Trump administration claims MFN could deliver $529B in ...
The PARP inhibitor clinical trial analysis report delivers important insights into ongoing research on 30+ PARP inhibitors in the pipeline, clinical strategies, upcoming therapeutics, and commercial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results